These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24303008)

  • 21. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
    Paquette JJ; Wang HY; Bakshi K; Olmstead MC
    Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
    Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
    Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.
    Dai E; Zhang J; Zhang D; Yang L; Wang Y; Jiang X; Ye L; Li X; Liu H; Ma J; Jiang H
    Hepatogastroenterology; 2014 Oct; 61(135):2052-61. PubMed ID: 25713910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.
    Nogueiras R; Veyrat-Durebex C; Suchanek PM; Klein M; Tschöp J; Caldwell C; Woods SC; Wittmann G; Watanabe M; Liposits Z; Fekete C; Reizes O; Rohner-Jeanrenaud F; Tschöp MH
    Diabetes; 2008 Nov; 57(11):2977-91. PubMed ID: 18716045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG
    Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism.
    Le Bacquer O; Lanchais K; Combe K; Van Den Berghe L; Walrand S
    J Cell Physiol; 2021 Apr; 236(4):2669-2683. PubMed ID: 32885412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.
    Wei Y; Wang X; Zhao F; Zhao PQ; Kang XL
    Mol Vis; 2013; 19():357-66. PubMed ID: 23441106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?
    Doggrell SA
    Expert Opin Pharmacother; 2005 Oct; 6(12):2141-4. PubMed ID: 16197364
    [No Abstract]   [Full Text] [Related]  

  • 32. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition.
    Orio L; Crespo I; López-Moreno JA; Reyes-Cabello C; Rodríguez de Fonseca F; Gómez de Heras R
    Pharmacol Biochem Behav; 2011 Apr; 98(2):220-6. PubMed ID: 21163296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
    Fattore L; Spano M; Melis V; Fadda P; Fratta W
    Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.
    Fride E; Braun H; Matan H; Steinberg S; Reggio PH; Seltzman HH
    Pediatr Res; 2007 Nov; 62(5):533-6. PubMed ID: 17805201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
    Cota D; Sandoval DA; Olivieri M; Prodi E; D'Alessio DA; Woods SC; Seeley RJ; Obici S
    Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; LeMay BJ; Vemuri VK; Vadivel SK; Zvonok A; Makriyannis A
    Psychopharmacology (Berl); 2011 Aug; 216(3):355-65. PubMed ID: 21369753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
    Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
    Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.
    Ward SJ; Lefever TW; Rawls SM; Whiteside GT; Walker EA
    Psychopharmacology (Berl); 2009 Sep; 206(1):155-65. PubMed ID: 19575185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids Regulate the Diameter of Pericyte-Containing Retinal Capillaries in Rats.
    Zong Y; Zhou X; Cheng J; Yu J; Wu J; Jiang C
    Cell Physiol Biochem; 2017; 43(5):2088-2101. PubMed ID: 29059679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.